Invesco
ETON icon

Invesco’s Eton Pharmaceutcials ETON Stock Holding History

Invesco’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$565K Buy
22,874
+3,183
+16% +$55.7K ﹤0.01% 3113
2025
Q4 		$333K Buy
19,691
+6,213
+46% +$109K ﹤0.01% 3344
2025
Q3 		$293K Hold
13,478
– – ﹤0.01% 3427
2025
Q2 		$192K Buy
+13,478
New +$213K ﹤0.01% 3520

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return

Invesco's ETON Position: Q1 2026 in Review

Invesco increased its Eton Pharmaceutcials (ETON) stake by 16% in Q1 2026, buying an estimated $55.7K and bringing the position to 22,874 shares worth $565K. The position accounts for ﹤0.01% of the portfolio, ranked #3113.

Invesco first reported a position in ETON in Q2 2025 and has held it in 4 quarters since. 116 funds tracked by Wall St. Rank hold ETON as of Q1 2026.

  • Invesco held 22,874 shares of Eton Pharmaceutcials worth $565K as of Q1 2026.
  • Invesco bought 3,183 Eton Pharmaceutcials shares in Q1 2026, an estimated $55.7K.
  • Eton Pharmaceutcials made up ﹤0.01% of Invesco's portfolio in Q1 2026, its #3113 holding.
  • Invesco first reported a position in Eton Pharmaceutcials in Q2 2025 and has held it in 4 quarters since.
  • 116 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q1 2026.

Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.